| Short Description : | Recombinant-Active-Human VSIG8-C-hFc protein was developed from mammalian cells and has a target region of C-hFc. For use in research applications. |
| Applications: | ELISA/WB |
| Host: | Mammalian Cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Dilution Range: | Reconstitute in sterile water for a stock solution. |
| Formulation: | Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol. |
| Storage Instruction: | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at-20 to-80°C for twelve months from the date of receipt. |
| Endotoxin: | <0.1 EU/Mu g of the protein by the LAL method. |
| Immunoreactivity: | Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 1-5 Mu g/mL. |
| Gene Symbol: | VSIG8 |
| Gene ID: | 391123 |
| Uniprot ID: | VSIG8_HUMAN |
| Immunogen: | Homo sapiens (Human) |
| Immunogen Region: | Val22-Gly263 |
| Database Links | |
| Cellular Localisation | MembraneSingle-Pass Type I Membrane Protein |
| Alternative Protein Names | V-Set And Immunoglobulin Domain-Containing Protein 8 proteinVSIG8 proteinC1orf204 protein |
Information sourced from Uniprot.org
